These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30987836)

  • 1. Plasma endothelin-1 and adrenomedullin are associated with coronary artery function and cardiovascular outcomes in humans.
    Theuerle J; Farouque O; Vasanthakumar S; Patel SK; Burrell LM; Clark DJ; Al-Fiadh AH
    Int J Cardiol; 2019 Sep; 291():168-172. PubMed ID: 30987836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary Flow Reserve and Microcirculatory Resistance in Patients With Intermediate Coronary Stenosis.
    Lee JM; Jung JH; Hwang D; Park J; Fan Y; Na SH; Doh JH; Nam CW; Shin ES; Koo BK
    J Am Coll Cardiol; 2016 Mar; 67(10):1158-1169. PubMed ID: 26965536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coronary microvascular resistance and its relevant factors in patients with moderate coronary stenosis and chest pain].
    He DF; Liu MY; Zhang LJ; Guo CJ; Chi YP; Zhao L; Zhang XJ
    Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):270-274. PubMed ID: 29614585
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Murai T; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Hamaya R; Kanno Y; Lee T; Kakuta T
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1063-1074. PubMed ID: 29446567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link of renal microcirculatory dysfunction to increased coronary microcirculatory resistance in hypertensive patients.
    Lin C; Zhang P; Xue Y; Huang Y; Ji K
    Cardiol J; 2017; 24(6):623-632. PubMed ID: 28653312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum endothelin-1 is an independent predictor of coronary microvascular dysfunction in non-obstructive territories in patients with coronary artery disease.
    Naya M; Aikawa T; Manabe O; Obara M; Koyanagawa K; Katoh C; Tamaki N
    Heart Vessels; 2021 Jul; 36(7):917-923. PubMed ID: 33484293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
    Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
    Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.
    Bajaj NS; Osborne MT; Gupta A; Tavakkoli A; Bravo PE; Vita T; Bibbo CF; Hainer J; Dorbala S; Blankstein R; Bhatt DL; Di Carli MF; Taqueti VR
    J Am Coll Cardiol; 2018 Aug; 72(7):707-717. PubMed ID: 30092946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
    Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.
    Taqueti VR; Everett BM; Murthy VL; Gaber M; Foster CR; Hainer J; Blankstein R; Dorbala S; Di Carli MF
    Circulation; 2015 Feb; 131(6):528-35. PubMed ID: 25480813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of assessing coronary flow velocity reserve and plasma endothelin-1 in hypertensive patients.
    Fujii H; Takiuchi S; Kamide K; Horio T; Niizuma S; Tanaka N; Hashimoto S; Nakatani S; Fukagawa M; Kawano Y
    Hypertens Res; 2005 Nov; 28(11):911-6. PubMed ID: 16555580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Local Myocardial Damage on Index of Microcirculatory Resistance and Fractional Flow Reserve in Target and Nontarget Vascular Territories in a Porcine Microvascular Injury Model.
    Lee JM; Kim HK; Lim KS; Park JK; Choi KH; Park J; Hwang D; Rhee TM; Yang JH; Shin ES; Nam CW; Doh JH; Hahn JY; Koo BK; Jeong MH
    JACC Cardiovasc Interv; 2018 Apr; 11(8):717-724. PubMed ID: 29605246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of smoking on coronary microcirculatory resistance in patients with coronary artery disease.
    Miyazaki T; Ashikaga T; Ohigashi H; Komura M; Kobayashi K; Isobe M
    Int Heart J; 2015; 56(1):29-36. PubMed ID: 25503655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cholesterol levels are associated with coronary microvascular dysfunction.
    Mangiacapra F; De Bruyne B; Peace AJ; Melikian N; Wijns W; Barbato E
    J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):439-42. PubMed ID: 22343265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure-derived estimations of coronary flow reserve are inferior to flow-derived coronary flow reserve as diagnostic and risk stratification tools.
    Wijntjens GWM; van Lavieren MA; van de Hoef TP; Echavarría-Pinto M; Meuwissen M; Stegehuis VE; Murai T; Escaned J; Piek JJ
    Int J Cardiol; 2019 Mar; 279():6-11. PubMed ID: 30482445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intimal hyperplasia and coronary flow reserve after heart transplantation: association with big endothelin-1.
    Wexberg P; Pacher R; Rödler S; Kiss K; Beran G; Grimm M; Maurer G; Glogar D
    J Heart Lung Transplant; 2002 Dec; 21(12):1257-63. PubMed ID: 12490270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.
    Taqueti VR; Hachamovitch R; Murthy VL; Naya M; Foster CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
    Circulation; 2015 Jan; 131(1):19-27. PubMed ID: 25400060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous and plasma changes of endothelin-1, adrenomedullin and vascular endothelium growth factor in patients with proliferative diabetic retinopathy.
    Vingolo EM; Fragiotta S; Mafrici M; Cutini A; Marinelli C; Concistrè A; Iannucci G; Petramala L; Letizia C
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):662-668. PubMed ID: 28272719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhomogeneous vasomotor effects of moderate selective and non-selective endothelin-receptor blockade in stable coronary artery disease.
    Wexberg P; Sperker W; Morgenthaler NG; Heinzl H; Adlbrecht C; Plass C; Glogar HD; Lang IM; Neunteufl T
    Heart; 2009 Aug; 95(15):1258-64. PubMed ID: 19414437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1.
    Verweij N; Mahmud H; Mateo Leach I; de Boer RA; Brouwers FP; Yu H; Asselbergs FW; Struck J; Bakker SJ; Gansevoort RT; Munroe PB; Hillege HL; van Veldhuisen DJ; van Gilst WH; Silljé HH; van der Harst P
    Hypertension; 2013 Mar; 61(3):602-8. PubMed ID: 23381795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.